Suppr超能文献

法国关于减重手术相关骨质疏松症的预防和治疗建议。

French recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery.

机构信息

University Lille, CHU Lille, MABlab ULR 4490, Department of Rheumatology, 59000 Lille, France.

Sorbonne Université, Department of Digestive and Hepato-Pancreato-Biliary Surgery, Liver Transplantation, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Institut Hospitalo-Universitaire ICAN, Paris, France.

出版信息

Joint Bone Spine. 2022 Nov;89(6):105443. doi: 10.1016/j.jbspin.2022.105443. Epub 2022 Jul 28.

Abstract

INTRODUCTION

This article presents the initial recommendations of the Groupe de Recherche et d'Information sur les Ostéoporoses (Osteoporosis Research and Information Group [GRIO]) and the Société Française de Rhumatologie (French Rheumatology Society [SFR]) on the prevention and treatment of osteoporosis secondary to bariatric surgery.

METHODS

The recommendations were produced by a working group comprising 4 expert rheumatologists, 3 medically qualified nutritionists, 2 obesity surgeons, 1 physical activity specialist, and 1 patient-association representative.

RESULTS

The following generally recommended measures apply to all patients with an indication for bariatric surgery or who have already undergone bariatric surgery: normalize calcium and protein intake, attain a 25(OH) vitamin D concentration of between 30 and 60ng/mL; prevent the risk of falls, and introduce a suitable regimen of physical activity. An initial assessment of fracture risk should be routinely performed - ideally before the first bariatric surgery procedure - (i) in the case of RYGB and biliopancreatic diversion, regardless of age, (ii) in patients at high risk of fracture, regardless of age, and (iii) in all menopausal women and all men ≥ 50 years old, regardless of the type of bariatric surgical procedure. The fracture risk assessment is based on a determination of osteoporosis risk factors and bone mineral density measurements. Anti-osteoporosis treatment - zoledronic acid as the first line of treatment - is indicated for menopausal women and men ≥ 50 years old with (i) a history of severe fracture, regardless of T-score, (ii) a history of non-severe fracture and a T-score ≤ -1, and (iii) no history of fracture and a T-score ≤ -2.

CONCLUSIONS

There is an increased risk of fracture after bariatric surgery. Clinicians should focus their attention on patients at high fracture risk such as postmenopausal women and men older than 50 years. More research is necessary to direct and support guidelines.

摘要

简介

本文介绍了 Groupe de Recherche et d'Information sur les Ostéoporoses(Osteoporosis Research and Information Group [GRIO])和 Société Française de Rhumatologie(法国风湿病学会 [SFR])关于预防和治疗肥胖症患者接受减重手术后发生的骨质疏松症的初步建议。

方法

这些建议由一个工作组提出,该工作组由 4 名专业风湿病专家、3 名具有医学资质的营养师、2 名肥胖症外科医生、1 名体力活动专家和 1 名患者协会代表组成。

结果

对于所有有减重手术适应证的患者或已接受减重手术的患者,以下是一般推荐的措施:正常摄入钙和蛋白质,使 25(OH) 维生素 D 浓度达到 30-60ng/mL;预防跌倒风险,并进行适当的体力活动。应常规进行骨折风险评估-理想情况下在第一次减重手术前进行-(i)对于 RYGB 和胆胰分流术,无论年龄如何;(ii)对于有高骨折风险的患者,无论年龄如何;(iii)对于所有绝经后妇女和所有 50 岁以上的男性,无论减重手术类型如何。骨折风险评估基于骨质疏松症风险因素的确定和骨密度测量。对于(i)有严重骨折史的绝经后妇女和 50 岁以上的男性,无论 T 评分如何;(ii)有非严重骨折史且 T 评分≤-1 的患者;(iii)无骨折史且 T 评分≤-2 的患者,建议使用唑来膦酸进行抗骨质疏松治疗作为一线治疗。

结论

减重手术后骨折风险增加。临床医生应关注高骨折风险患者,如绝经后妇女和 50 岁以上男性。需要更多的研究来指导和支持指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验